Trial Profile
Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- Acronyms ICE-T
- 11 May 2017 Status changed from not yet recruiting to recruiting.
- 14 Feb 2017 New trial record